30th Mar 2006 12:07
Sinclair Pharma PLC30 March 2006 30 March 2006 Sinclair Pharma plc Director's Share Dealing Sinclair Pharma plc (LSE: SPH) ("Sinclair" or the "Company") announces that itwas informed today that the Directors named in the table below yesterday boughtOrdinary Shares of 1 pence each at a price of 125 pence per share as part of avendor placing to fund the acquisition of Groupe CS Dermatologie SAS announcedon 13 March 2006. The holdings of these Directors following these purchases of shares are alsogiven in the table below: Name Role Purchase Holding after Holding after purchase purchase (No. of shares) (No. of shares) (Percentage of ISC) Andrew Sinclair Non-Executive Director 1,200,000 6,165,192 6.61%Michael Flynn Chief Executive Officer 240,000 9,409,300 10.09%Jerry Randall Chief Financial Officer 80,000 465,000 0.50% - Ends - Enquiries: Sinclair Pharma plc Tel: 01483 426644Michael Flynn, Chief Executive OfficerJerry Randall, Chief Financial Officer Further information on Sinclair can be found on the company's website:www.sinclairpharma.com This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma